home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Revolution Medicines Announces Proposed Public Offering of Common Stock
Revolution Medicines Announces Proposed Public Offering of Common Stock
Post navigation
Previous Post
Previous
Revolution Medicines Reports New Application of Tri-Complex Modality for “Undruggable” Protein Targets and Announces License to Ginkgo Bioworks to Explore Potential Use Against Novel Coronavirus
Next Post
Next
Kronos Bio Appoints Industry Veteran, Jennifer Nicholson, M.H.A., as Vice President, Regulatory Affairs